Plasma biomarkers such as CRP and PCT are insufficiently sensitive or specific in predicting the onset of severe septic shock, ARDS and COVID-19-related acute viral septic shock in these critically ill patients [17, 24, 25]. This evidence concerns the gene CRP and septic shock.